Arrowhead Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 21.32 M | $1.42 B | 5.41% | 15.22% |
| VANGUARD GROUP INC | 01/29/2026 | 15.29 M | $1,015.31 B | -4.63% | 10.92% |
| STATE STREET CORP | 02/13/2026 | 6.40 M | $425.15 M | 0.10% | 4.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.26 M | $216.80 B | 4.28% | 2.33% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 2.09 M | $138.62 M | 0.30% | 1.49% |
| NORGES BANK | 02/10/2026 | 1.70 M | $113.16 M | 100.00% | 1.22% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 1.68 M | $111.37 B | -5.43% | 1.20% |
| SIREN, L.L.C. | 02/13/2026 | 1.50 M | $99.62 M | -43.80% | 1.07% |
| MORGAN STANLEY | 02/13/2026 | 1.48 M | $97.99 M | -13.31% | 1.05% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.35 M | $89.87 M | 0.58% | 0.97% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 1.31 M | $87.09 M | 24.48% | 0.94% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 1.26 M | $83.68 M | -28.37% | 0.90% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.03 M | $68.64 M | 253.49% | 0.76% |
| UBS GROUP AG | 01/29/2026 | 987.29 K | $65.55 M | 7.53% | 0.71% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 887.85 K | $58.94 M | 9.00% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 859.90 K | $57.09 M | 61.00% | 0.61% |
| WESTERN FINANCIAL CORP/CA | 01/21/2026 | 820.24 K | $54.46 M | 0.00% | 0.60% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 715.54 K | $47.50 M | -8.28% | 0.53% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 684.89 K | $45.47 M | 79.94% | 0.50% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 663.26 K | $44.03 M | 432.62% | 0.47% |
| JPMORGAN CHASE & CO | 02/11/2026 | 611.91 K | $40.62 M | -21.12% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 622.03 K | $41.30 B | -18.23% | 0.44% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 478.51 K | $31.77 M | -11.28% | 0.34% |
| CITADEL ADVISORS LLC | 02/17/2026 | 474.26 K | $31.49 B | 49.32% | 0.34% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 422.73 K | $28.07 M | 207.41% | 0.30% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/03/2026 | 398.20 K | $26.44 M | -15.98% | 0.29% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 395.31 K | $26.24 M | 2.31% | 0.28% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 375.37 K | $24.92 M | 100.00% | 0.27% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 370.00 K | $24.56 M | 100.00% | 0.26% |
| RHUMBLINE ADVISERS | 02/13/2026 | 352.40 K | $23.40 B | -5.04% | 0.25% |
| NORDEA INVESTMENT MANAGEMENT AB | 01/08/2026 | 324.25 K | $21.57 M | -12.90% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 331.50 K | $22.01 M | 107.84% | 0.24% |
| BARCLAYS PLC | 02/13/2026 | 321.83 K | $21.37 M | -8.11% | 0.23% |
| ABRDN PLC | 01/16/2026 | 286.15 K | $19.00 M | -45.04% | 0.21% |
| NUVEEN, LLC | 02/12/2026 | 288.58 K | $19.16 M | 3.68% | 0.21% |
| FENGHE FUND MANAGEMENT PTE. LTD. | 01/30/2026 | 266.70 K | $17.71 M | 100.00% | 0.20% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 242.07 K | $16.07 M | -1.62% | 0.18% |
| SWISS NATIONAL BANK | 02/12/2026 | 245.40 K | $16.29 M | 14.62% | 0.18% |
| JANE STREET GROUP, LLC | 02/12/2026 | 244.00 K | $16.20 B | 157.66% | 0.17% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 237.73 K | $15.78 M | 14.32% | 0.17% |
| CITADEL ADVISORS LLC | 02/17/2026 | 234.10 K | $15.54 B | 85.94% | 0.17% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 208.06 K | $13.81 M | -46.81% | 0.15% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/10/2026 | 193.85 K | $12.87 M | 100.00% | 0.14% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 198.39 K | $13.17 M | -12.71% | 0.14% |
| PINNACLE ASSOCIATES LTD | 02/05/2026 | 191.67 K | $12.72 M | -5.73% | 0.14% |
| PEAK6 LLC | 02/13/2026 | 171.20 K | $11.37 M | 122.05% | 0.12% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 01/28/2026 | 159.54 K | $10.59 M | -0.90% | 0.12% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/12/2026 | 159.53 K | $10.59 M | 100.00% | 0.11% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 01/30/2026 | 149.78 K | $9.94 M | 0.88% | 0.11% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 152.51 K | $10.12 M | 90.08% | 0.11% |
Arrowhead Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 431 institutional investors and hedge funds held shares of Arrowhead Pharmaceuticals Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 21.32 M
VANGUARD GROUP INC: 15.29 M
STATE STREET CORP: 6.4 M
GEODE CAPITAL MANAGEMENT, LLC: 3.26 M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 2.09 M
NORGES BANK: 1.7 M
85.04% of Arrowhead Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 116.41 M shares in the last 24 months. This purchase volume represents approximately $7.43 B in transactions.